Kewaunee Scientific Co. (NASDAQ:KEQU) Director Acquires $19,747.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) Director Keith M. Gehl acquired 403 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was purchased at an average price of $49.00 per share, for a total transaction of $19,747.00. Following the completion of the purchase, the director now directly owns 17,000 shares in the company, valued at $833,000. This trade represents a 2.43 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Kewaunee Scientific Price Performance

Shares of KEQU traded down $1.36 during midday trading on Tuesday, hitting $49.69. 31,923 shares of the company traded hands, compared to its average volume of 22,252. The stock has a 50-day moving average of $58.39 and a 200-day moving average of $47.80. Kewaunee Scientific Co. has a one year low of $30.82 and a one year high of $71.33. The firm has a market cap of $142.71 million, a P/E ratio of 7.87 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%. The firm had revenue of $67.17 million for the quarter.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of KEQU. Invesco Ltd. purchased a new position in shares of Kewaunee Scientific during the fourth quarter worth about $6,545,000. Marshall Wace LLP purchased a new position in shares of Kewaunee Scientific during the fourth quarter worth about $736,000. De Lisle Partners LLP grew its holdings in shares of Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after purchasing an additional 11,511 shares in the last quarter. Truffle Hound Capital LLC purchased a new position in shares of Kewaunee Scientific during the fourth quarter worth about $619,000. Finally, State Street Corp purchased a new position in shares of Kewaunee Scientific during the third quarter worth about $266,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.